Related references
Note: Only part of the references are listed.Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 Tumors
Ken Kageyama et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
The future of CpG immunotherapy in cancer
Behnam Badie et al.
IMMUNOTHERAPY (2013)
Radiofrequency Ablation and Immunostimulant OK-432: Combination Therapy Enhances Systemic Antitumor Immunity for Treatment of VX2 Lung Tumors in Rabbits
Shinichi Hamamoto et al.
RADIOLOGY (2013)
Hsp70, a messenger from hyperthermia for the immune system
Anna Jolesch et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization
Y. Nakamoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
Time-Course Studies of Implanted Rabbit VX2 Liver Tumors to Identify the Appropriate Time for Starting Hepatic Arterial Embolization in Animal Models
Akinaga Sonoda et al.
ONCOLOGY (2011)
Combination strategies for enhancing the efficacy of immunotherapy in cancer patients
Federica Moschella et al.
THYMOSINS IN HEALTH AND DISEASE (2010)
Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
Kazuhiko Yamada et al.
CANCER SCIENCE (2010)
Therapeutic Cancer Vaccines in Combination with Conventional Therapy
Mads Hald Andersen et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Immunotherapy for Melanoma: Current Status and Perspectives
Doru T. Alexandrescu et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
Noriaki Nakai et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases
Thomas Josef Vogl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Dendritic cell-based therapeutic cancer vaccines: what we have and what we need
Pawel Kalinski et al.
FUTURE ONCOLOGY (2009)
Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells
Rebecca J. Dearman et al.
IMMUNOLOGY (2009)
CD40-Independent Engagement of Mammalian hsp70 by Antigen-Presenting Cells
Robert J. Binder
JOURNAL OF IMMUNOLOGY (2009)
Abrogation of Local Cancer Recurrence After Radiofrequency Ablation by Dendritic Cell-based Hyperthermic Tumor Vaccine
Qiong Liu et al.
MOLECULAR THERAPY (2009)
Radiofrequency Ablation Induces Antigen-presenting Cell Infiltration and Amplification of Weak Tumor-induced Immunity
Sergio A. Dromi et al.
RADIOLOGY (2009)
Radiofrequency ablation and chemoembolization for hepatocellular carcinoma
Christos S. Georgiades et al.
CANCER JOURNAL (2008)
Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer
Christian Manegold et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation
Alessandro Zerbini et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients
Julien Fourcade et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating protein
Robert J. Binder et al.
JOURNAL OF IMMUNOLOGY (2007)
CPG-7909 (PF-3512676, ProMune®):: toll-like receptor-9 agonist in cancer therapy
Yanal M. Murad et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity
M. H. M. G. M. den Brok et al.
BRITISH JOURNAL OF CANCER (2006)
Patterns of heat shock protein (HSP70) expression and Kupffer cell activity following thermal ablation of liver and colorectal liver metastases
M Nikfarjam et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2005)
Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation
WL Yang et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro
S Rothenfusser et al.
BLOOD (2004)
Enhancement of the immune response to residual intrahepatic tumor tissue by laser-induced thermotherapy (LITT) compared to hepatic resection
C Isbert et al.
LASERS IN SURGERY AND MEDICINE (2004)
Percutaneous US-guided radiofrequency ablation with perfused needle applicators: Improved survival with the VX2 tumor model in rabbits
J Hansler et al.
RADIOLOGY (2004)
'The stress of ding': the role of heat shock proteins in the regulation of apoptosis
HM Beere
JOURNAL OF CELL SCIENCE (2004)
Treatment of hepatocellular carcinoma: is there an optimal strategy?
M Varela et al.
CANCER TREATMENT REVIEWS (2003)
Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model
K Heckelsmiller et al.
JOURNAL OF IMMUNOLOGY (2002)
Immunopharmacology of CpG DNA
A Dalpke et al.
BIOLOGICAL CHEMISTRY (2002)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
Immunohistochemical investigation of the cross-reactivity of selected cell markers from various species for characterization of lymphatic tissues in the harbour porpoise (Phocoena phocoena)
A Beineke et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2001)
Toll-like receptors: critical proteins linking innate and acquired immunity
S Akira et al.
NATURE IMMUNOLOGY (2001)
Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity
E Davila et al.
JOURNAL OF IMMUNOLOGY (2000)